Medical task force says more people should be taking HIV prevention drug
The U.S. Preventive Services Task Force issued a recommendation on Tuesday in the pursuit of HIV prevention. Pre-exposure prophylaxis, also known as PrEP, has been proven effective in preventing people from getting HIV if it's taken regularly, and the task force is now suggesting that people who are at risk of being infected should have access to a daily pill to lower their likelihood of contracting the disease. The recommendation letter was published in the Journal of the American Medical Association alongside an editorial by two physicians involved in HIV research.
While the Centers for Disease Control and Prevention has long recommended PrEP as "a powerful HIV prevention tool," less than 10 percent of at-risk individuals currently take it, NPR reports. People at high risk include men who have sex with other men, as well as people who inject drugs — and "black and Latino men who have sex with men" are among the people whose rate of getting PrEP is especially low, despite their risk, details the editorial.
While treatment for HIV has improved vastly since its discovery, little progress has been made in preventing new cases. One factor could be the cost of preventive medicine: PrEP can cost over $20,000 for a year's supply. Lack of awareness could be another — having unprotected sex with a partner who hasn't disclosed their HIV status presents a high risk as well.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Read more about PrEP and the U.S. Preventive Services Task Force's recommendation at NPR.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Shivani is the editorial assistant at TheWeek.com and has previously written for StreetEasy and Mic.com. A graduate of the physics and journalism departments at NYU, Shivani currently lives in Brooklyn and spends free time cooking, watching TV, and taking too many selfies.
-
Fallout: one of the 'most faithful – and best – video game adaptations'
The Week Recommends This 'genre-bending' new Amazon series is set in a post-apocalyptic wilderness where survivors shelter below ground
By Adrienne Wyper, The Week UK Published
-
'Test of faith for Trump Media's investors'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Will Iran attack hinder support for Ukraine?
Today's Big Question Pro-Kyiv allies cry 'hypocrisy' and 'double standards' even as the US readies new support package
By Elliott Goat, The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published